본문 바로가기
KERD
논문KCI 등재

네트워크 약리학을 활용한 메니에르병에 대한 二陳湯의 활성 성분과 치료 기전 연구(Ⅰ)

Analysis of the Active Compounds and Therapeutic Mechanisms of Yijin-tang on Meniere's Disease Using Network Pharmacology(Ⅰ)

남혜정|진선경
대한한방안이비인후피부과학회 (The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society)|2023.02|한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology)|제36권 제1호|pp. 50-63

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

Yijin-tangMeniere's diseaseNetwork Pharmacology
주제분류한의학

초록

Objectives : This study used a network pharmacology approach to explore the active compounds and therapeutic mechanisms of Yijin-tang on Meniere's disease. Methods : The active compounds of Yijin-tang were screened via the TCMSP database and their target proteins were screened via the STITCH database. The GeneCard was used to establish the Meniere's disease-related genes. The intersection targets were obtained through Venny 2.1.0. The related protein interaction network was constructed with the STRING database, and topology analysis was performed through CytoNCA. GO biological function analysis and KEGG enrichment analysis for core targets were performed through the ClueGO. Results : Network analysis identified 126 compounds in five herbal medicines of Yijin-tang. Among them, 15 compounds(naringenin, beta-sitosterol, stigmasterol, baicalein, baicalin, calycosin, dihydrocapsaicin, formononetin, glabridin, isorhamnetin, kaempferol, mairin, quercetin, sitosterol, nobiletin) were the key chemicals. The target proteins were 119, and 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were linked to Meniere's disease-related genes. Core genes in this network were TNF, CASP9, and NOS2. GO/KEGG pathway analysis results indicate that these targets are primarily involved in regulating biological processes, such as excitotoxicity, oxidative stress, and apoptosis. Conclusion : Pharmacological network analysis can help to explain the applicability of Yijin-tang on Meniere's disease.

Abstract

Objectives : This study used a network pharmacology approach to explore the active compounds and therapeutic mechanisms of Yijin-tang on Meniere's disease. Methods : The active compounds of Yijin-tang were screened via the TCMSP database and their target proteins were screened via the STITCH database. The GeneCard was used to establish the Meniere's disease-related genes. The intersection targets were obtained through Venny 2.1.0. The related protein interaction network was constructed with the STRING database, and topology analysis was performed through CytoNCA. GO biological function analysis and KEGG enrichment analysis for core targets were performed through the ClueGO. Results : Network analysis identified 126 compounds in five herbal medicines of Yijin-tang. Among them, 15 compounds(naringenin, beta-sitosterol, stigmasterol, baicalein, baicalin, calycosin, dihydrocapsaicin, formononetin, glabridin, isorhamnetin, kaempferol, mairin, quercetin, sitosterol, nobiletin) were the key chemicals. The target proteins were 119, and 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were linked to Meniere's disease-related genes. Core genes in this network were TNF, CASP9, and NOS2. GO/KEGG pathway analysis results indicate that these targets are primarily involved in regulating biological processes, such as excitotoxicity, oxidative stress, and apoptosis. Conclusion : Pharmacological network analysis can help to explain the applicability of Yijin-tang on Meniere's disease.

참고문헌 (36)

  1. Espinosa-Sanchez JM, "Handbook of clinical neurology, 137", pp.257~277 (2016)
  2. Yokota Y, "Surgical results and psychological status in patients with intractable Ménière's disease", Auris Nasus Larynx, 43(3), pp.287~291 (2016)
  3. Baloh RW, "Harold Schuknecht and pathology of the ear", Otology & neurotology, 22(1), pp.113~122 (2001)
  4. Kiang NYS., "An auditory physiologist's view of Meniere's syndrome", 2nd Int Symp Men Dis, pp.13~24 (1989), Kugler
  5. Jung SC, "The bibliographicol study on Yijin-tang(sang)", Journal of Haehwa Medicine, 11(1), pp.29~41 (2002)
  6. Park WH, "The bibliographicol study on Dam-Eum", The Journal of Dong Guk Oriental Medicine, 1(1), pp.141~160 (1992)
  7. 정혜진, "메니에르 병의 병리기전에 대한 최신 연구 동향과 한의학적 고찰", 한방안이비인후피부과학회지, 30(3), pp.103~118 (2017), 대한한방안이비인후피부과학회[DOI]
  8. Li S, "Network pharmacology in traditional Chinese medicine", Evidence-based complementary and alternative medicine, 2014, pp.2~ (2014)
  9. Lee WY, "The methodological trends of traditional herbal medicine employing network pharmacology", Biomolecules, 9(8), pp.362~ (2019)
  10. Lee AY, "Network pharmacology-based prediction of active compounds and molecular targets in Yijin-Tang acting on hyperlipidaemia and atherosclerosis", Journal of Ethnopharma-cology, 221, pp.151~159 (2018)
  11. Liu H, "Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease", The Anatomical Record, 304(11), pp.2605~2619 (2021)
  12. Ding S, "Exploring miRNA-related molecular targets of erchen decoction against lipid metabolism disorder using A network pharmacologic approach", Combinatorial Chemistry & High Throughput Screening, 25(6), pp.986~997 (2022)
  13. Bradley J, "TNF-mediated inflammatory disease", The Journal of Pathology : A Journal of the Pathological Society of Great Britain and Ireland, 214(2), pp.149~160 (2008)
  14. Frejo L, "Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease", Scientific reports, 8(1), pp.1~11 (2018)
  15. Patel JA, "Association of proin-flammatory cytokine gene polymorphisms with susceptibility to otitis media", Pediatrics, 118(6), pp.2273~2279 (2006)
  16. Keithley EM, "Tumor necrosis factor α can induce recruitment of inflammatory cells to the cochlea", Otology & Neurotology, 29(6), pp.854~859 (2008)
  17. Huang CJ, "CASP9 genotype confers gentamicin susceptibility in intratympanic treatment of intractable vertigo caused by Ménière’s disease", Acta Oto-Laryngologica, 139(4), pp.336~339 (2019)
  18. Junet P, "Vestibular results after intratympanic gentamicin therapy in disabling Menière’s disease", European Archives of Oto-Rhino-Laryngology, 273(10), pp.3011~3018 (2016)
  19. Cunningham LL, "Caspase activation in hair cells of the mouse utricle exposed to neomycin", Journal of Neuroscience, 22(19), pp.8532~8540 (2002)
  20. MacMicking J, "Nitric oxide and macrophage function", Annual review of immunology, 15, pp.323~ (1997)
  21. Hess A, "Expression of inducible nitric oxide synthase(iNOS", NOS II)in the cochlea of guinea pigs after intratympanical endotoxin-treatment, 1999, pp.830(1), 113~122
  22. Lechner M, "Inducible nitric oxide synthase(iNOS) in tumor biology: the two sides of the same coin", Seminars in cancer biology, 15(4), pp.277~289 (2005)
  23. Michel O, "Expression of inducible nitric oxide synthase(iNOS", NOS II)in the hydropic cochlea of guinea pigs, 2000, pp.143(1, 2), 23~28
  24. Msiv NP, "Sodium nitroprusside", nitric oxide causes apoptosis in spiral ganglion cells, 1998, pp.119(4), 323~330
  25. Ishiyama G, "The blood labyrinthine barrier in the human normal and Meniere’s disease macula utricle", Scientific reports, 7(1), pp.1~10 (2017)
  26. Ishiyama G, "Oxidative stress in the blood labyrinthine barrier in the macula utricle of Meniere’s disease patients", Frontiers in Physiology, 9, pp.1068~ (2018)
  27. Süslü N, "Utility of immunologic parameters in the evaluation of Meniere's disease", Acta oto-laryngologica, 129(11), pp.1160~1165 (2009)
  28. Gazquez I, "Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in Ménière's disease in a European Caucasian population", DNA and cell biology, 30(9), pp.699~708 (2011)
  29. Merchant SN, "Pathophysiology of Meniere's syndrome : are symptoms caused by endolymphatic hydrops?", Otology & Neurotology, 26(1), pp.74~81 (2005)
  30. Semaan MT, "The basic science of Meniere's disease and endolymphatic hydrops", Current opinion in otolaryngology & head and neck surgery, 13(5), pp.301~307 (2005)
  31. Lidia Frejo, "Cytokines and Inflammation in Meniere Disease", Clinical and Experimental Otorhinolaryngology, 15(1), pp.49~59 (2022), 대한이비인후과학회[DOI]
  32. Pazzaglia S, "Multifaceted role of PARP-1 in DNA repair and inflammation : pathological and therapeutic implications in cancer and non-cancer diseases", Cells, 9(1), pp.41~ (2019)
  33. Morgenstern C, "Pathogenesis of experimental endolymphatic hydrops", Acta Oto-Laryngologica, 96(406), pp.56~58 (1983)
  34. Pawankar R, "Interferon-gamma expression in the inner ear of rats following secondary immune reaction in the endolymphatic sac", Acta Otolaryngol Suppl, 553, pp.6~12 (2004)
  35. Satoh H, "Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation", Journal of the Association for Research in Otolaryngology, 4(2), pp.139~147 (2003)
  36. Matsubara A, "Cystic fibrosis transmembrane conductance regulator in the endolymphatic sac of the rat", Auris Nasus Larynx, 41(5), pp.409~412 (2014)

관련 논문AI추천

네트워크 약리학을 활용한 메니에르병에 대한 二陳湯의 활성 성분과 치료 기전 연구(Ⅱ)남혜정, 진선경대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2023 · 제36권 제2호돌발성 난청 치료 한약 처방의 네트워크 분석박인화, 이규영대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제3호메니에르병에 대한 苓桂朮甘湯의 효과: 체계적 문헌고찰 및 메타분석김기서, 오정화, 윤화정대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제3호노인성 난청의 한약 치료에 대한 체계적 문헌고찰: 腎虛을 중점으로고우신, 윤화정, 임희영, 진한솔대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2021 · 제34권 제4호네트워크 약리학적 방법론을 활용한 한의학 효능 연구 고찰권영규, 백종민, 서한길한의병리학회 · 동의생리병리학회지2016 · 제30권 제6호Cisplatin에 의한 耳毒性에서 苓桂朮甘湯의 보호 효과박래길, 소홍섭, 이수경, 전호성, 정명수한의병리학회 · 동의생리병리학회지2012 · 제26권 제5호

이 간행물의 다른 논문 (8건)

湯火止痛散의 NF-κB 및 MAPK 억제를 통한 항염증 효과황보민, 고민정, 지선영pp. 1-20槐花散의 NF-κB 기전을 통한 항염증 효과 연구황보민, 최지영, 지선영, 조현희pp. 21-39淸肺瀉肝湯의 피부 항노화 효과에 대한 연구김희택, 전보희, 송영채, 김용민pp. 40-49건성안 증후군에 대한 전자뜸과 침의 효과 비교 임상연구박수연, 송지훈, 최정화, 정민영, 박지식pp. 64-77Efficacy and Safety of a Biodegradable Hyaluronic Acid Microneedle Patch for Dry Skin in Atopic Dermatitis: A Single-blinded, Split-body, Randomized Controlled Trial이기현, 정민영, 박수연, 최정화, 송지훈pp. 78-95
원문 보기